Additional Effects of Sternocleidomastoid Release With SNAGS in the Management of Cervicogenic Headache

July 30, 2024 updated by: Foundation University Islamabad
Cervicogenic headache is a common type of headache in adults which causes disability and difficulty in everyday activities. According to the latest International Headache Society model, cervicogenic headache (CGH) is a secondary headache having C1-C2 dysfunction. SNAGs are highly effective in the treatment approach for these patients. Sternocleidomastoid muscle receive overactive tension from forward neck posture, increasing muscular fatigue and tone of muscles. This tension in SCM causes referred pain in the head and neck region. SNAGs are very effective but musculoskeletal impairments especially the tightness of sternocleidomastoid muscle still persist and can exacerbate symptoms. Manual therapy targeted to the SCM muscle may be effective for reducing headache and neck pain intensity and increasing performance of deep cervical flexors. Findings of this study will aid the therapists in choosing which technique to use while treating the patients. This will save therapist's time and effort as they will not be using the less effective treatment protocol. Furthermore, patient's time and investment will be used in the right direction.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Rawalpindi, Punjab, Pakistan, 46000
        • Foundation University College of Physical Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age group: 18-45 years old
  • Both males and females
  • Unilateral headache with no shift of side
  • C1-C2 Dysfunction
  • Positive flexion rotation test (Rotation restriction is greater than 10 degrees)
  • Headache at least once a month in the last 3 months
  • Headache with at least 4 score in NPRS (Sign and Symptoms of Neck Involvement)
  • Headache with restriction of ROM in the neck
  • Headache precipitated by:

Sustained neck movements, and awkward head positioning. External Pressure over upper cervical or occipital region

Headache Characteristics:

  • Moderate-severe, non-throbbing pain, usually starting in the neck.
  • Episodes of varying duration, or: fluctuating, continuous pain

Exclusion Criteria:

  • Headache of non-cervical origin
  • Diagnosed Cases of:Cervical spondylosis,Cervical radiculopathy/ nerve root involvement/ disc herniation,Cervical instability/ fracture,Vertebrobasilar insufficiency ,Cervical spine surgery,Cervical spondylolisthesis,Spinal infection or tumors,Osteoporosis,History of trauma,Rheumatoid Arthritis,Inflammatory Arthritis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Conventional physical therapy Group

Both Group A and Group B will receive this conventional physical therapy protocol for cervicogenic headache.

  • Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
  • TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.

In addition to this, they will receive Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.

• Frequency: 3 times a week for 2 weeks. 6 sessions in total.

Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.

• TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.

Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.

• Frequency: 3 times a week for 2 weeks. 6 sessions in total.

Experimental: Conventional physical therapy with sternocleidomastoid release

Both Group A and Group B will receive this conventional physical therapy protocol for cervicogenic headache.

  • Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
  • TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.

Headache SNAGs: In addition to the conventional physical therapy protocol, they will receive Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.

  • Frequency: 3 times a week for 2 weeks. 6 sessions in total. Sternocleidomastoid Release: Group B will also receive Sternocleidomastoid release in addition with headache SNAGs. Release to the sternocleidomastoid muscle will be given once per session for 5-8 minutes.
  • Frequency: 3 times a week for 2 weeks. 6 sessions in total.

Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.

• TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.

Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.

• Frequency: 3 times a week for 2 weeks. 6 sessions in total.

Sternocleidomastoid Release: Group B will also receive Sternocleidomastoid release in addition with headache SNAGs. Release to the sternocleidomastoid muscle will be given once per session for 5-8 minutes.Frequency: 3 times a week for 2 weeks. 6 sessions in total.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity
Time Frame: 2 weeks
Pain will be measured on the basis of Numeric Pain Rating Scale score.
2 weeks
Range of motion
Time Frame: 2 weeks
Cervical rotation will be measured through CROM device
2 weeks
Headache Disability
Time Frame: 2 weeks
Headache Disability Index will be used
2 weeks
Cervical Proprioception
Time Frame: 2 weeks
Joint Position Error Test will be used
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 10, 2024

Primary Completion (Estimated)

December 10, 2024

Study Completion (Estimated)

December 30, 2024

Study Registration Dates

First Submitted

July 30, 2024

First Submitted That Met QC Criteria

July 30, 2024

First Posted (Actual)

August 2, 2024

Study Record Updates

Last Update Posted (Actual)

August 2, 2024

Last Update Submitted That Met QC Criteria

July 30, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervicogenic Headache

Clinical Trials on Electrotherapy and physical agents

Subscribe